Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 6 of 6 entries
View as:

A Phase I/II Study With CEA(6D) VRP Vaccine in Patients With Advanced or Metastatic CEA-Expressing Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00529984 Org: User:
Start: 09/30/07 End: 05/31/10 Due: 05/31/11

Safety of and Immune Response to an HIV-1 Subtype C Vaccine (AVX101) in HIV Uninfected Adults

Phase: N/A Priority: Normal
NCT ID: NCT00097838 Org: User:
Start: 10/31/04 End: 09/30/09 Due: 09/30/10

A Safety and Immunogenicity Trial in Adults 65 Years of Age or Over to Prevent Influenza

Phase: N/A Priority: Normal
NCT ID: NCT00706732 Org: User:
Start: 06/30/08 End: 03/31/09 Due: 03/31/10

A Phase 1/2 Clinical Trial of an Alphavirus Replicon Vaccine for Influenza

Phase: N/A Priority: Normal
NCT ID: NCT00440362 Org: User:
Start: 04/30/07 End: 09/30/07 Due: 09/30/08

A Clinical Trial of an Alphavirus Replicon Vaccine for Cytomegalovirus (CMV)

Phase: N/A Priority: Normal
NCT ID: NCT00439803 Org: User:
Start: 04/30/07 End: 07/31/08 Due: 07/31/09

Safety of an HIV Vaccine (AVX101) in HIV Uninfected Volunteers in the United States and South Africa

Phase: N/A Priority: Normal
NCT ID: NCT00063778 Org: User:
Start: 07/31/03 End: 07/31/05 Due: 07/31/06